vs

Side-by-side financial comparison of Global Medical REIT Inc. (GMRE) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.

RE/MAX Holdings, Inc. is the larger business by last-quarter revenue ($71.1M vs $38.4M, roughly 1.9× Global Medical REIT Inc.). RE/MAX Holdings, Inc. runs the higher net margin — 2.0% vs -16.0%, a 18.0% gap on every dollar of revenue. On growth, Global Medical REIT Inc. posted the faster year-over-year revenue change (9.2% vs -1.8%). Over the past eight quarters, Global Medical REIT Inc.'s revenue compounded faster (4.6% CAGR vs -4.7%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.

GMRE vs RMAX — Head-to-Head

Bigger by revenue
RMAX
RMAX
1.9× larger
RMAX
$71.1M
$38.4M
GMRE
Growing faster (revenue YoY)
GMRE
GMRE
+11.0% gap
GMRE
9.2%
-1.8%
RMAX
Higher net margin
RMAX
RMAX
18.0% more per $
RMAX
2.0%
-16.0%
GMRE
Faster 2-yr revenue CAGR
GMRE
GMRE
Annualised
GMRE
4.6%
-4.7%
RMAX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GMRE
GMRE
RMAX
RMAX
Revenue
$38.4M
$71.1M
Net Profit
$-6.1M
$1.4M
Gross Margin
Operating Margin
13.1%
Net Margin
-16.0%
2.0%
Revenue YoY
9.2%
-1.8%
Net Profit YoY
-309.2%
-75.2%
EPS (diluted)
$-0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GMRE
GMRE
RMAX
RMAX
Q4 25
$38.4M
$71.1M
Q3 25
$37.2M
$73.2M
Q2 25
$38.0M
$72.8M
Q1 25
$34.6M
$74.5M
Q4 24
$35.2M
$72.5M
Q3 24
$34.3M
$78.5M
Q2 24
$34.2M
$78.5M
Q1 24
$35.1M
$78.3M
Net Profit
GMRE
GMRE
RMAX
RMAX
Q4 25
$-6.1M
$1.4M
Q3 25
$-5.1M
$4.0M
Q2 25
$585.0K
$4.7M
Q1 25
$3.7M
$-2.0M
Q4 24
$2.9M
$5.8M
Q3 24
$3.4M
$966.0K
Q2 24
$-2.0M
$3.7M
Q1 24
$2.3M
$-3.4M
Operating Margin
GMRE
GMRE
RMAX
RMAX
Q4 25
13.1%
Q3 25
25.0%
Q2 25
19.3%
Q1 25
7.2%
Q4 24
5.9%
Q3 24
19.4%
Q2 24
20.6%
Q1 24
5.8%
Net Margin
GMRE
GMRE
RMAX
RMAX
Q4 25
-16.0%
2.0%
Q3 25
-13.6%
5.4%
Q2 25
1.5%
6.4%
Q1 25
10.8%
-2.6%
Q4 24
8.4%
8.0%
Q3 24
9.9%
1.2%
Q2 24
-5.7%
4.7%
Q1 24
6.6%
-4.3%
EPS (diluted)
GMRE
GMRE
RMAX
RMAX
Q4 25
$-0.48
Q3 25
$-0.45
Q2 25
$-0.01
Q1 25
$0.03
Q4 24
$-0.04
Q3 24
$0.14
Q2 24
$-0.05
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GMRE
GMRE
RMAX
RMAX
Cash + ST InvestmentsLiquidity on hand
$9.1M
$118.7M
Total DebtLower is stronger
$1.2M
$432.2M
Stockholders' EquityBook value
$509.8M
$452.4M
Total Assets
$1.2B
$582.5M
Debt / EquityLower = less leverage
0.00×
0.96×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GMRE
GMRE
RMAX
RMAX
Q4 25
$9.1M
$118.7M
Q3 25
$7.1M
$107.5M
Q2 25
$6.6M
$94.3M
Q1 25
$5.4M
$89.1M
Q4 24
$6.8M
$96.6M
Q3 24
$5.7M
$83.8M
Q2 24
$5.0M
$66.1M
Q1 24
$1.3M
$82.1M
Total Debt
GMRE
GMRE
RMAX
RMAX
Q4 25
$1.2M
$432.2M
Q3 25
$1.2M
$433.3M
Q2 25
$14.2M
$434.4M
Q1 25
$14.3M
$435.3M
Q4 24
$14.4M
$436.2M
Q3 24
$14.5M
$437.2M
Q2 24
$14.7M
$438.1M
Q1 24
$25.7M
$439.0M
Stockholders' Equity
GMRE
GMRE
RMAX
RMAX
Q4 25
$509.8M
$452.4M
Q3 25
$485.3M
$448.1M
Q2 25
$503.2M
$442.4M
Q1 25
$517.4M
$433.5M
Q4 24
$534.1M
$429.5M
Q3 24
$542.6M
$423.1M
Q2 24
$556.4M
$418.4M
Q1 24
$575.0M
$412.0M
Total Assets
GMRE
GMRE
RMAX
RMAX
Q4 25
$1.2B
$582.5M
Q3 25
$1.3B
$582.2M
Q2 25
$1.3B
$574.8M
Q1 25
$1.3B
$571.4M
Q4 24
$1.3B
$581.6M
Q3 24
$1.2B
$578.6M
Q2 24
$1.2B
$571.4M
Q1 24
$1.3B
$566.7M
Debt / Equity
GMRE
GMRE
RMAX
RMAX
Q4 25
0.00×
0.96×
Q3 25
0.00×
0.97×
Q2 25
0.03×
0.98×
Q1 25
0.03×
1.00×
Q4 24
0.03×
1.02×
Q3 24
0.03×
1.03×
Q2 24
0.03×
1.05×
Q1 24
0.04×
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GMRE
GMRE
RMAX
RMAX
Operating Cash FlowLast quarter
$73.6M
$40.9M
Free Cash FlowOCF − Capex
$33.5M
FCF MarginFCF / Revenue
47.1%
Capex IntensityCapex / Revenue
10.4%
Cash ConversionOCF / Net Profit
28.39×
TTM Free Cash FlowTrailing 4 quarters
$56.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GMRE
GMRE
RMAX
RMAX
Q4 25
$73.6M
$40.9M
Q3 25
$17.6M
$17.7M
Q2 25
$22.1M
$4.6M
Q1 25
$12.3M
$5.7M
Q4 24
$70.0M
$59.7M
Q3 24
$16.3M
$17.6M
Q2 24
$18.9M
$15.9M
Q1 24
$14.3M
$9.4M
Free Cash Flow
GMRE
GMRE
RMAX
RMAX
Q4 25
$33.5M
Q3 25
$16.4M
Q2 25
$2.9M
Q1 25
$4.0M
Q4 24
$53.0M
Q3 24
$16.3M
Q2 24
$14.0M
Q1 24
$6.8M
FCF Margin
GMRE
GMRE
RMAX
RMAX
Q4 25
47.1%
Q3 25
22.4%
Q2 25
4.0%
Q1 25
5.3%
Q4 24
73.2%
Q3 24
20.8%
Q2 24
17.8%
Q1 24
8.6%
Capex Intensity
GMRE
GMRE
RMAX
RMAX
Q4 25
10.4%
Q3 25
1.8%
Q2 25
2.2%
Q1 25
2.3%
Q4 24
9.1%
Q3 24
1.7%
Q2 24
2.4%
Q1 24
3.3%
Cash Conversion
GMRE
GMRE
RMAX
RMAX
Q4 25
28.39×
Q3 25
4.45×
Q2 25
37.84×
0.97×
Q1 25
3.28×
Q4 24
23.83×
10.28×
Q3 24
4.81×
18.22×
Q2 24
4.29×
Q1 24
6.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GMRE
GMRE

Segment breakdown not available.

RMAX
RMAX

Franchising Segment$50.1M70%
Broker Fees$13.9M20%
Annual Dues$7.4M10%

Related Comparisons